» Articles » PMID: 30387809

N-acetylcysteine Alleviates H2O2-induced Damage Via Regulating the Redox Status of Intracellular Antioxidants in H9c2 Cells

Overview
Journal Int J Mol Med
Specialty Genetics
Date 2018 Nov 3
PMID 30387809
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

N‑acetylcysteine (NAC) is a thiol‑containing antioxidant that modulates the intracellular redox state. NAC can scavenge reactive oxygen species (ROS) and maintain reduced glutathione (GSH) levels, in order to protect cardiomyocytes from oxidative stress. The present study aimed to determine whether NAC protects cardiomyocytes from oxidative damage by regulating the redox status of intracellular antioxidant proteins. The results revealed that NAC pretreatment increased cell viability and inhibited the activation of caspase‑3, ‑8 and ‑9 during hydrogen peroxide (H2O2)‑induced oxidative stress in H9c2 cells. Furthermore, decreased ROS levels, and increased total and reduced GSH levels were detected in response to NAC pretreatment. Non‑reducing redox western blotting was performed to detect the redox status of intracellular antioxidant proteins, including thioredoxin 1 (Trx1), peroxiredoxin 1 (Prx1), GSH reductase (GSR), and phosphatase and tensin homolog (PTEN). The results revealed that the reduced form of Trx1 was markedly increased, and the oxidized forms of Prx1, GSR and PTEN were decreased following NAC pretreatment. Furthermore, NAC pretreatment decreased H2O2‑induced phosphorylation of apoptosis signal‑regulating kinase 1, which depends on the redox state of Trx1, and increased H2O2‑induced phosphorylation of protein kinase B, which is essential to cell survival. To the best of our knowledge, the present study is the first to reveal that NAC pretreatment may alleviate oxidation of intracellular antioxidant proteins to inhibit oxidative stress‑induced cardiomyocyte apoptosis.

Citing Articles

Formation of multinucleated osteoclasts depends on an oxidized species of cell surface-associated La protein.

Leikina E, Whitlock J, Melikov K, Zhang W, Bachmann M, Chernomordik L Elife. 2024; 13.

PMID: 39356057 PMC: 11446546. DOI: 10.7554/eLife.98665.


Identification of Autophagy-Related Genes in Patients with Acute Spinal Cord Injury and Analysis of Potential Therapeutic Targets.

Su X, Wang S, Tian Y, Teng M, Wang J, Zhang Y Mol Neurobiol. 2024; 62(3):2674-2694.

PMID: 39150631 DOI: 10.1007/s12035-024-04431-x.


Development of a Novel Amplifiable System to Quantify Hydrogen Peroxide in Living Cells.

Wang L, Lin H, Yang B, Jiang X, Chen J, Roy Chowdhury S J Am Chem Soc. 2024; 146(32):22396-22404.

PMID: 39079063 PMC: 11722959. DOI: 10.1021/jacs.4c05366.


FORMATION OF MULTINUCLEATED OSTEOCLASTS DEPENDS ON AN OXIDIZED SPECIES OF CELL SURFACE ASSOCIATED LA PROTEIN.

Leikina E, Whitlock J, Melikov K, Zhang W, Bachmann M, Chernomordik L bioRxiv. 2024; .

PMID: 38903088 PMC: 11188106. DOI: 10.1101/2024.05.02.592254.


CircRNA itchy E3 ubiquitin protein ligase improves mitochondrial dysfunction in sepsis-induced acute kidney injury by targeting microRNA-214-3p/ATP-binding cassette A1 axis.

Ye W, Miao Q, Xu G, Jin K, Li X, Wu W Ren Fail. 2023; 45(2):2261552.

PMID: 37782276 PMC: 10547449. DOI: 10.1080/0886022X.2023.2261552.


References
1.
Wu D, Liang M, Dang H, Fang F, Xu F, Liu C . Hydrogen protects against hyperoxia-induced apoptosis in type II alveolar epithelial cells via activation of PI3K/Akt/Foxo3a signaling pathway. Biochem Biophys Res Commun. 2017; 495(2):1620-1627. DOI: 10.1016/j.bbrc.2017.11.193. View

2.
Hanschmann E, Godoy J, Berndt C, Hudemann C, Lillig C . Thioredoxins, glutaredoxins, and peroxiredoxins--molecular mechanisms and health significance: from cofactors to antioxidants to redox signaling. Antioxid Redox Signal. 2013; 19(13):1539-605. PMC: 3797455. DOI: 10.1089/ars.2012.4599. View

3.
Wang T, Mao X, Li H, Qiao S, Xu A, Wang J . N-Acetylcysteine and allopurinol up-regulated the Jak/STAT3 and PI3K/Akt pathways via adiponectin and attenuated myocardial postischemic injury in diabetes. Free Radic Biol Med. 2013; 63:291-303. DOI: 10.1016/j.freeradbiomed.2013.05.043. View

4.
Lillig C, Berndt C, Holmgren A . Glutaredoxin systems. Biochim Biophys Acta. 2008; 1780(11):1304-17. DOI: 10.1016/j.bbagen.2008.06.003. View

5.
Whayne Jr T, Parinandi N, Maulik N . Thioredoxins in cardiovascular disease. Can J Physiol Pharmacol. 2015; 93(11):903-11. DOI: 10.1139/cjpp-2015-0105. View